AGO Research GmbH
Quick facts
Marketed products
- PLD · Oncology
PLD is a pegylated liposomal doxorubicin that delivers the chemotherapy agent doxorubicin within lipid nanoparticles to reduce systemic toxicity while maintaining anti-tumor efficacy.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: